Galectin Therapeutics
GALT
#8659
Rank
A$0.20 B
Marketcap
$3.26
Share price
-3.29%
Change (1 day)
36.65%
Change (1 year)

Galectin Therapeutics (GALT) - Net assets

Net assets on the balance sheet as of September 2024 : -A$0.15 Billion

According to Galectin Therapeutics's latest financial reports the company has -A$0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galectin Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$-A$47.31 Million-1411.09%
2021-12-31$A$3.6 M-88.53%
2020-12-31$A$31.46 M-51.69%
2019-12-31$A$65.12 M565.08%
2018-12-31$A$9.79 M540.77%
2017-12-31$A$1.52 M-90.83%
2016-12-31$A$16.66 M-51.52%
2015-12-31$A$34.38 M0.59%
2014-12-31$A$34.18 M270.6%
2013-12-31$A$9.22 M21.07%
2012-12-31$A$7.61 M77.65%
2011-12-31$A$4.28 M-357.14%
2010-12-31$-A$1.67 Million-66.46%
2009-12-31$-A$4.98 Million648.04%
2008-12-31$-A$0.67 Million-80.12%
2007-12-31$-A$3.35 Million11883.84%
2006-12-31$-A$0.03 Million-100.57%
2005-12-31$A$4.89 M-62.5%
2004-12-31$A$13.05 M27.31%
2003-12-31$A$10.25 M257.51%
2002-12-31$A$2.86 M20.42%
2001-12-31$A$2.38 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$1.50 B-1,123.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.34 Billion 126.99%๐Ÿ‡บ๐Ÿ‡ธ USA